BreastCancer Archives - Next Click News

Combo Cancer Drugs Outperform Chemo Alone in Key Breast Cancer Subgroups

Recent research presented at the European Society for Medical Oncology (ESMO) meeting shows that antibody-drug conjugates (ADCs) significantly improve outcomes for certain breast cancer patients when used alongside chemotherapy. For patients with aggressive triple-negative breast cancer who cannot get immunotherapy, Trodelvy extended median progression-free survival to 9.7 months, compared to 6.9 months with standard chemo….

Gilead’s Trodelvy Reduces Risk in Aggressive Breast Cancer by 38%

Aisha Ajaz3 weeks ago3 weeks ago01 mins

Trodelvy, developed by Gilead Sciences, has delivered promising results in a late-stage trial for advanced triple-negative breast cancer (TNBC). Researchers found that the drug lowered the risk of disease progression by 38% compared to standard chemotherapy. The study enrolled 558 patients with TNBC whose tumours did not express PD-L1. Participants receiving Trodelvy reached a median…

AstraZeneca’s Datroway Extends Survival in Hard-to-Treat Breast Cancer

Aisha Ajaz3 weeks ago3 weeks ago02 mins

AstraZeneca and Daiichi Sankyo have announced that their new drug Datroway significantly improved survival in patients with aggressive triple-negative breast cancer (TNBC). The results were revealed at the European Society for Medical Oncology (ESMO) Congress in Berlin. In the trial, patients receiving Datroway achieved a median overall survival of 23.7 months versus 18.7 months for those treated with standard chemotherapy….